The syndrome of apparent mineralocorticoid excess and deficiency of 11 β‐hydroxysteroid dehydrogenase
- 1 August 1995
- journal article
- editorial
- Published by Wiley in Clinical Endocrinology
- Vol. 43 (2) , 247-248
- https://doi.org/10.1111/j.1365-2265.1995.tb01924.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mineralocorticoid hypertension and congenital deficiency of 11β‐hydroxysteroid dehydrogenase in a family with the syndrome of‘apparent’mineralocorticoid excessClinical Endocrinology, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- 11 -BETA-HYDROXYSTEROID DEHYDROGENASEJournal Of Hypertension, 1994
- Linkage of 17 β-oestradiol dehydrogenase to actin by ɛ-(γ-glutamyl)-lysine in porcine endometrial cellsBiochemical Journal, 1993
- Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.Hypertension, 1992
- Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, MediatedScience, 1988
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988
- Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.Journal of Clinical Investigation, 1988